MetaVia Inc.
MTVAHealthcare|Biotechnology|US
$1.43
+0.34 (+31.19%)
DCF Value
$5.15
Tangible Book / Share
$1.15
Cash / Share
$2.13
Financials
Financial Snapshot
Market Cap
$9.4M
Enterprise Value
-$3.0M
Revenue (TTM)
$0.00
Net Income (TTM)
-$14.4M
Cash & Investments
$12.6M
Net Cash
$12.5M
Free Cash Flow (TTM)
-$15.8M
Operating CF (TTM)
-$15.8M
Debt/Equity
0.03
Cash Runway & Burn Rate
Cash on Hand
$12.6M
Quarterly Burn
$4.0M
Monthly Burn
$1.3M
Est. Runway
~3.2 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $24.0M | $18.5M | $2.8M | $13.9M | $10.1M | $16.4M | $33.4M | $22.4M | $16.0M | $10.3M | $12.6M | |
| Operating Cash Flow | -$11.0M | -$26.9M | -$14.5M | -$7.0M | -$10.8M | -$15.1M | -$11.7M | -$10.8M | -$24.7M | -$15.7M | -$15.8M | |
| Free Cash Flow | -$11.0M | -$26.9M | -$14.5M | -$7.3M | -$10.8M | -$15.1M | -$11.7M | -$10.8M | -$24.7M | -$15.7M | -$15.8M | |
| Capital Expenditure | $0.00 | $0.00 | -$3.0K | -$214.0K | -$4.0K | -$3.0K | $0.00 | -$50.0K | -$8.0K | -$2.0K | $0.00 | |
| Financing Cash Flow | $31.5M | $21.3M | $17.2M | $24.2M | $6.9M | $22.0M | $28.7M | -$80.0K | $18.3M | $10.0M | $10.9M |
R&D Spending
R&D (TTM)
$7.7M
R&D Intensity
—
R&D Growth vs Prior
+13.7%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $8.7M | $22.7M | $13.9M | $17.5M | $21.9M | $6.5M | $2.8M | $9.2M | $21.5M | $6.8M | $7.7M | |
| SG&A | $6.0M | $10.4M | $1.6M | $2.7M | $7.8M | $8.8M | $8.6M | $6.7M | $7.3M | $6.9M | $7.2M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $67.0K | $72.0K | $28.0K | $7.0K | $24.0K | $19.0K | $10.0K | |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | -$67.0K | -$72.0K | -$28.0K | -$7.0K | -$24.0K | -$19.0K | -$10.0K | |
| R&D | $8.7M | $22.7M | $13.9M | $17.5M | $21.9M | $6.5M | $2.8M | $9.2M | $21.5M | $6.8M | $7.7M | |
| SG&A | $6.0M | $10.4M | $1.6M | $2.7M | $7.8M | $8.8M | $8.6M | $6.7M | $7.3M | $6.9M | $7.2M | |
| Operating Income | -$14.7M | -$33.1M | -$15.5M | -$20.2M | -$29.7M | -$15.3M | -$19.6M | -$15.9M | -$28.8M | -$13.7M | -$14.9M | |
| Interest Expense | $0.00 | $286.0K | $40.0K | $22.0K | $0.00 | $0.00 | $2.2M | $0.00 | $0.00 | $0.00 | $0.00 | |
| Pretax Income | -$14.6M | -$33.4M | -$15.5M | -$21.3M | -$29.7M | -$15.3M | -$14.0M | -$12.5M | -$27.6M | -$13.0M | -$14.4M | |
| Net Income | -$14.6M | -$33.4M | -$15.5M | -$21.3M | -$29.7M | -$15.3M | -$14.0M | -$12.5M | -$27.6M | -$13.0M | -$14.4M | |
| EPS (Diluted) | -106454.37 | -213180.00 | -112860.00 | -10771.20 | -4831.20 | -1742.40 | -477.84 | -27.06 | -39.16 | -7.35 | -4.07 | |
| EBITDA | -$14.7M | -$33.1M | -$15.5M | -$20.2M | -$29.7M | -$15.2M | -$11.8M | -$12.5M | -$27.6M | -$13.0M | -$14.5M | |
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.46 | 0.71 | 1.77 | 5.93 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.0M | $18.5M | $2.8M | $13.9M | $10.1M | $16.4M | $33.4M | $22.4M | $16.0M | $10.3M | $12.6M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $24.7M | $19.0M | $3.8M | $14.1M | $10.7M | $16.6M | $33.5M | $22.5M | $16.1M | $10.9M | $13.1M | |
| Total Assets | $24.8M | $19.0M | $3.8M | $14.5M | $11.0M | $16.8M | $33.5M | $22.8M | $16.3M | $69.1M | $13.3M | |
| Total Current Liabilities | $4.1M | $6.4M | $219.0K | $2.1M | $3.7M | $2.2M | $11.8M | $6.0M | $8.3M | $5.6M | $6.3M | |
| Long-Term Debt | $0.00 | $8.7M | $118.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $4.1M | $15.1M | $17.1M | $2.2M | $3.8M | $2.2M | $11.8M | $6.1M | $8.3M | $63.8M | $6.4M | |
| Stockholders' Equity | $20.6M | $3.9M | -$13.3M | $12.3M | $7.2M | $14.6M | $21.8M | $16.7M | $7.9M | $5.3M | $6.8M | |
| Retained Earnings | -$27.1M | -$60.5M | -$15.6M | -$36.9M | -$66.5M | -$81.8M | -$95.8M | -$108.3M | -$135.9M | -$148.8M | -$158.0M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$11.0M | -$26.9M | -$14.5M | -$7.0M | -$10.8M | -$15.1M | -$11.7M | -$10.8M | -$24.7M | -$15.7M | -$15.8M | |
| Capital Expenditure | $0.00 | $0.00 | -$3.0K | -$214.0K | -$4.0K | -$3.0K | $0.00 | -$50.0K | -$8.0K | -$2.0K | $0.00 | |
| Free Cash Flow | -$11.0M | -$26.9M | -$14.5M | -$7.3M | -$10.8M | -$15.1M | -$11.7M | -$10.8M | -$24.7M | -$15.7M | -$15.8M | |
| Investing Cash Flow | $0.00 | $0.00 | -$3.0K | -$6.1M | $69.0K | -$586.0K | $8.0K | -$50.0K | -$8.0K | -$2.0K | $0.00 | |
| Financing Cash Flow | $31.5M | $21.3M | $17.2M | $24.2M | $6.9M | $22.0M | $28.7M | -$80.0K | $18.3M | $10.0M | $10.9M | |
| Issuance of Stock | $30.3M | $12.5M | $25.1M | $0.00 | $7.5M | $24.0M | $32.3M | -$80.0K | $20.0M | $10.0M | $11.2M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $5.2M | $10.0M | $500.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $1.7M | $5.3M | $0.00 | $118.0K | $699.0K | $662.0K | $854.0K | $222.0K | $538.0K | $411.0K | $398.0K | |
| Net Change in Cash | $20.4M | -$5.6M | $2.8M | $11.1M | -$3.8M | $6.3M | $17.0M | -$10.9M | -$6.4M | -$5.7M | -$5.0M |
Dilution Tracker
Shares outstanding grew 28648.6% over 5 years — significant dilution
Shares Outstanding
7M
5-Year Share Growth
+28648.6%
Stock Issuance (TTM)
$11.2M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.46 | 0.71 | 1.77 | 5.93 | |
| Change vs Prior % | — | 12.1% | 33.1% | 846.9% | 210.4% | 42.7% | 233.6% | 1476.3% | 53.0% | 150.4% | 235.9% | |
| Stock Issuance | $30.3M | $12.5M | $25.1M | $0.00 | $7.5M | $24.0M | $32.3M | -$80.0K | $20.0M | $10.0M | $11.2M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $1.7M | $5.3M | $0.00 | $118.0K | $699.0K | $662.0K | $854.0K | $222.0K | $538.0K | $411.0K | $398.0K |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | -70.7% | -847.9% | 116.9% | -173.4% | -412.0% | -104.7% | -64.2% | -74.7% | -347.9% | -243.3% | -209.7% | |
| ROA % | -58.9% | -175.7% | -406.5% | -147.3% | -270.6% | -91.0% | -41.7% | -54.7% | -169.7% | -18.8% | -108.9% | |
| ROIC % | -71.2% | -236.9% | -118.8% | -162.6% | -407.2% | -104.3% | -90.2% | -94.1% | -357.1% | -21.6% | -213.3% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Gross Profit | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -7.5% | 61.1% | 75.0% | -242.9% | 20.8% | |
| Operating Income | -82.0% | -125.4% | 53.2% | -30.3% | -47.3% | 48.5% | -28.3% | 19.1% | -81.3% | 52.4% | |
| Net Income | -61.5% | -129.1% | 53.5% | -37.2% | -39.3% | 48.5% | 8.6% | 10.7% | -121.3% | 53.0% | |
| EPS (Diluted) | -13.5% | -100.3% | 47.1% | 90.5% | 55.1% | 63.9% | 72.6% | 94.3% | -44.7% | 81.2% | |
| Operating Cash Flow | -103.3% | -143.6% | 46.3% | 51.3% | -52.9% | -40.6% | 22.6% | 7.8% | -128.8% | 36.5% | |
| Free Cash Flow | -103.3% | -143.6% | 46.3% | 49.8% | -48.5% | -40.6% | 22.6% | 7.4% | -127.8% | 36.5% | |
| R&D Expense | 119.0% | 159.6% | -38.8% | 25.9% | 25.2% | -70.1% | -57.6% | 229.7% | 135.1% | -68.4% | |
| SG&A Expense | 87.5% | 75.3% | -84.6% | 68.3% | 190.5% | 11.5% | -1.3% | -22.1% | 7.8% | -5.1% | |
| Total Assets | 451.3% | -23.2% | -79.9% | 278.7% | -24.2% | 53.2% | 99.6% | -32.1% | -28.6% | 325.1% | |
| Book Value / Share | 265.5% | -83.0% | -353.2% | 109.8% | -81.1% | 42.0% | -55.3% | -95.1% | -68.9% | -73.1% | |
| Debt | -100.0% | 0.0% | -4.6% | -98.8% | -19.0% | -24.5% | -100.0% | 0.0% | -33.0% | 54.4% | |
| Diluted Shares | 0.7% | 12.1% | 33.1% | 846.9% | 210.4% | 42.7% | 233.6% | 1476.3% | 53.0% | 150.4% |
Valuation
P/E (TTM)At Loss
P/S0.00
P/B1.24
10Y Low / Med / High0.00 / 0.02 / 2.79
EV/EBITDA0.21
10Y Low / Med / High0.00 / 0.75 / 2.77
EV/Revenue0.00
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$5.15
Tangible Book / Share
$1.15
Net Current Assets / Share
$1.00
Graham Net-Net
$1.04
Cash / Share
$2.13
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.06 | -1.03 | -0.57 | -1.15 | -0.35 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/B Ratio | 0.00 | 0.00 | -0.00 | 0.00 | 0.02 | 0.02 | 0.04 | 0.77 | 1.99 | 2.79 | 1.24 | |
| EV/EBITDA | 1.64 | 0.25 | -0.44 | 0.68 | 0.33 | 1.05 | 2.77 | 0.75 | 0.00 | -0.37 | 0.21 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
-18.79
Distress
Piotroski F-Score
0
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.4M | -$4.2M | -$3.1M |
| EPS | $-2.52 | $-2.37 | $-1.66 |
| # Analysts (EPS) | 2 | 2 | 3 |